Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Date:11/9/2011

uled Financial Results Call Arena will host a conference call and webcast to discuss the third quarter 2011 financial results and to provide a business and financial update tomorrow, November 10, 2011, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time).

The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Third Quarter 2011 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

Upcoming Corporate PresentationsArena is planning to present at upcoming investment and industry conferences, including:

  • Piper Jaffray 23rd Annual Health Care Conference, November 29-30, 2011, New York, New York
  • 30th Annual J.P. Morgan Healthcare Conference, January 9-12, 2012, San Francisco, California

  • About LorcaserinLorcaserin is an investigational drug candidate intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (BMI greater than or equal to 30) or patients who are overweight (BMI greater than or equal to 27) and have at least one weight-related co-morbid condition. Lorcaserin is a new chemical entity that is believed to act as a selective serotonin 2C receptor agonist. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area believed to be involved in the control of appetite and metabolism. Arena has patents that cover lorcaserin in the United States and other jurisdictions that in most cases are capable of continuing into 2023 without taking into acco
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    2. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
    3. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
    4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
    5. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
    6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
    7. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
    8. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
    9. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
    10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
    11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)...   About ELISA test ELISA test ... is used for measuring the concentration of analytes such ... various types of enzymes such as carbonic anhydrase, glucose ... by photometry or fluorometry. ELISA is used as a ... such as HIV, pernicious anemia, rotavirus, Rocky Mountain spotted ...
    (Date:9/2/2015)... 2015 STAAR Surgical Company (NASDAQ: STAA ), ... delivery systems for the eye, today announced that its Board ... the Company,s Board. Mr. Wall was formerly ... -based investment firm, for more than nine years. Mr. ... and chair of the Corporate Governance Committee and member of ...
    (Date:9/2/2015)... , Sept. 2, 2015 Research and ... the "Inhaled Drug Delivery (London, UK - November ... This Inhaled Drug Delivery meeting will cover industry case ... much more. The Co-Chairmen are Dr Steven Nichols ... Senior Director, Mylan. Companies participating include: ...
    Breaking Medicine Technology:Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3William P. Wall Appointed to STAAR Surgical Board of Directors 2
    ... NEW YORK, Dec. 13, 2010 Pfizer Inc. (NYSE: ... Directors has elected George A. Lorch, 68, who has served ... the Board, effective immediately. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ... said, "George Lorch has been a valuable, independent voice on ...
    ... Company announced today that it has suspended its global ... compound, as a second-line treatment for those with unresectable ... with an independent data monitoring committee, recommended a "full ... hold ensures that no new or existing patients in ...
    Cached Medicine Technology:Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman 2Lilly Suspends Phase III Trial in Metastatic Melanoma 2Lilly Suspends Phase III Trial in Metastatic Melanoma 3
    (Date:9/3/2015)... York, New York (PRWEB) , ... September 03, 2015 , ... ... of the Division of Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical ... College. , Dr. Winchell is a nationally renowned expert in care for the critically ...
    (Date:9/3/2015)... , ... September 03, 2015 , ... Global Vision ... that it will be spotlighting its award-winning print and artwork inspection solutions, ScanProof ... September 16 and 17 at the Olympia London, booth #F33 , Be the first ...
    (Date:9/3/2015)... ... September 03, 2015 , ... ... its upcoming virtual conference, “Proven Pharmacy Benefit Strategies for a Rapidly Changing Marketplace.” ... Health, Express Scripts and Milliman, will discuss how plan sponsors are adopting bold, ...
    (Date:9/3/2015)... , ... September 03, 2015 , ... Hunters Creek ... Survivor Foundation with a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited ... for friends and family to enjoy Thanksgiving and Christmas with an extra big smile. ...
    (Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
    Breaking Medicine News(10 mins):Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2
    ... Needs of Life Science Companies, Health Care ProvidersLIBERTYVILLE, ... a leader in digital sales and marketing solutions, ... the nation,s leading provider of online, on-demand prescription ... a wholly owned subsidiary of Physicians Interactive LLC. ...
    ... Alliance Creates the Nation,s Largest Independent Online Retailer ... Million CustomersNEW YORK, March 24 Sandow Media, ... e-commerce Web site SpaLook.com, and Salu Beauty, parent ... deliver unprecedented scale and reach for beauty product ...
    ... Gather to Discuss Interactive Patient Care, Patient Engagement ... GetWellNetwork, Inc., the leading provider of ... highly successful conference, GetConnected2009 . ... GetConnected2009 is the industry,s leading annual ...
    ... Month , HARRISBURG, Pa., April 1 The Department ... for men and women to take steps to prevent ... well as the importance of discussing their sexual health ... are treatable, screening and early diagnosis are essential to ...
    ... at 5:00 p.m. EDT -- SOUTH SAN FRANCISCO, ... SNSS ) today announced the execution of a ... private placement of up to $43.5 million in a ... convertible preferred stock and common stock warrants, and a ...
    ... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... was elected to the company,s board of directors. Dr. Adashi, ... Care and in the Life Sciences was also appointed to ...
    Cached Medicine News:Health News:Physicians Interactive Acquires MedManage Systems 2Health News:Physicians Interactive Acquires MedManage Systems 3Health News:NewBeauty Magazine and SpaLook.com Create Strategic Alliance With Salu Beauty and SkinStore.com 2Health News:NewBeauty Magazine and SpaLook.com Create Strategic Alliance With Salu Beauty and SkinStore.com 3Health News:Innovation and Sharing of Client Successes Highlight GetWellNetwork's GetConnected2009 Conference 2Health News:Innovation and Sharing of Client Successes Highlight GetWellNetwork's GetConnected2009 Conference 3Health News:Innovation and Sharing of Client Successes Highlight GetWellNetwork's GetConnected2009 Conference 4Health News:Pennsylvania Department of Health Urges Greater Awareness of, Testing for Sexually Transmitted Diseases 2Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 2Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 3Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 4Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 5Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 6Health News:Eli Y. Adashi, MD, MS, FACOG, Joins Inverness Medical Innovations' Board of Directors 2
    Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
    Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
    Intended for the quantitative determination of direct bilirubin in serum. Modified EvelynMalloy Method. Endpoint Reaction. Wavelength: 555 nm. Linearity: 20 mg/dl (340 mol/l)...
    ... microplate spectrophotometer designed specifically to run 24 ... With rugged hardware, proven optical performance and ... of traditional spectrophotometry to obtain results quickly, ... read up to eight, 1 cm Biocell ...
    Medicine Products: